Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Disease × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 15 Non-Muscle Invasive Bladder Neoplasms 12 Carcinoma, Transitional Cell 9 Anus Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Stomach Neoplasms 2 Colonic Neoplasms 2 Anal Canal Carcinoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pseudomyxoma Peritonei 1 Pancreatic Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mesothelioma, Malignant 1 Hyperthermia 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Disease 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3 Positron-Emission Tomography 2 Injections 2 fluciclovine F-18 1 Thalidomide 1 Prednisone 1 Mitomycin 1 Melphalan 1 Lenalidomide 1 Dexamethasone 1 Cyclophosphamide 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03335059 2020-04-15

RITE-USA

Medical Enterprises Ltd.

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡